← The Wire
TOVXNYSE
Theriva Biologics, Inc.
Pharmaceutical Preparations · NV · CIK 894158
Developing oncolytic adenovirus therapeutics to treat cancer and related diseases
$14M
Market cap
$0.26
Last close
+4.1%
1D
+2.8%
5D
1.2M
Volume
Price · last 39 sessions-31.5%
May 4L $0.24 · H $0.38Jun 29
572
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
SC 13GSCHEDULE 13GOct 3, 2024SC 13GSC 13GOct 2, 2024SC 13GSC 13GFeb 10, 2021SC 13GSABBY 13G SYN 1.17.19Jan 17, 2019SC 13GSC 13GOct 18, 2018SC 13GSC 13GFeb 14, 2017SC 13GSABBY 13G SYN 11.17.16Nov 17, 2016SC 13GSC 13GMar 1, 2016SC 13GSCHEDULE 13GAug 4, 2015SC 13GSC 13GOct 20, 2014SC 13GSCHEDULE 13GApr 11, 2011SC 13GAEDEONA PHARMACEUTICALS, INC SC13GJan 31, 2011SC 13GADEONA PHARMACEUTICALS, INC.Jan 28, 2011SC 13GSC 13GJul 9, 2010SC 13GSCHEDULE 13G--ADEONA/STERGISFeb 12, 2010SC 13GSCHEDULE 13G--ADEONA/STERGISFeb 12, 2010SC 13GSC 13GDec 8, 2006SC 13GSCHEDULE 13GNov 29, 2006SC 13GSC 13GFeb 23, 2001SC 13GSC 13GMar 11, 1998
Similar companies
Comparable business profile · signals at a glance